Critical enzymes involved in endocannabinoid metabolism.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Protein Peptide Letters

• Publication date

  2007-02-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/092986607780090829PMID 17346227PMCID PMC1939815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic Impairment of Frontocortical Endocannabinoid Degradation and High Alcohol Preference

  2007cited by this paper
• Handbook of Neurochemistry and Molecular Neurobiology: Practical Neurochemistry Methods

  2007cited by this paper
• Role of Endocannabinoids in Alcohol Consumption and Intoxication: Studies of Mice Lacking Fatty Acid Amide Hydrolase

  2007cited by this paper
• Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine*

  2007cited by this paper
• A biosynthetic pathway for anandamide

  2006cited by this paper
• Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.

  2006cited by this paper
• Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol

  2006cited by this paper
• PGE2 glycerol ester, a COX‐2 oxidative metabolite of 2‐arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons

  2006cited by this paper
• Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling.

  2006cited by this paper
• Endocannabinoid Biosynthesis Proceeding through Glycerophospho-N-acyl Ethanolamine and a Role for α/β-Hydrolase 4 in This Pathway*

  2006cited by this paper
• A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals*

  2006cited by this paper
• Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.

  2006cited by this paper
• Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids.

  2006cited by this paper
• Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses

  2006cited by this paper
• Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.

  2006cited by this paper
• Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice.

  2006cited by this paper
• Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors

  2006cited by this paper
• Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus

  2005cited by this paper
• Structure and function of fatty acid amide hydrolase.

  2005cited by this paper
• Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats

  2005cited by this paper
• Endocannabinoid system and alcohol addiction: pharmacological studies.

  2005cited by this paper
• Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase*

  2005cited by this paper
• Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide

  2005cited by this paper
• Endocannabinoids restrict hippocampal long-term potentiation via CB1.

  2005cited by this paper
• Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones

  2005cited by this paper
• Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)

  2005cited by this paper
• Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus

  2004cited by this paper
• Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D.

  2004cited by this paper
• Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala

  2004cited by this paper
• Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.

  2004cited by this paper
• Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners*

  2004cited by this paper
• Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.

  2003cited by this paper
• Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

  2003cited by this paper
• Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons.

  2003cited by this paper
• Evidence against the presence of an anandamide transporter

  2003cited by this paper
• Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

  2003cited by this paper
• Cellular accumulation of anandamide: consensus and controversy

  2003cited by this paper
• 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain.

  2002cited by this paper
• Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.

  2002cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• A missense mutation in human fatty acid amide hydrolase associated with problem drug use

  2002cited by this paper
• Cannabinoid receptors.

  2002cited by this paper
• Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides*

  2002cited by this paper
• Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.

  2002cited by this paper
• Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide.

  2002cited by this paper
• Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling

  2002cited by this paper
• Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

  2002cited by this paper
• Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals.

  2001cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

  2001cited by this paper
• The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase*

  2001cited by this paper
• Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.

  2001cited by this paper
• Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene.

  2001cited by this paper
• Anandamide degradation and N‐acylethanolamines level in wild‐type and CB1 cannabinoid receptor knockout mice of different ages

  2001cited by this paper
• Cerebellar Depolarization-Induced Suppression of Inhibition Is Mediated by Endogenous Cannabinoids

  2001cited by this paper
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• Structure—Activity Relationships Among N‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter

  2000cited by this paper
• Oxidative metabolism of anandamide.

  2000cited by this paper
• Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.

  2000cited by this paper
• Carrier‐mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2‐arachidonylglycerol

  2000cited by this paper
• Human mast cells take up and hydrolyze anandamide under the control of 5‐lipoxygenase and do not express cannabinoid receptors

  2000cited by this paper
• Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain.

  2000cited by this paper
• Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons.

  2000cited by this paper
• Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain. A (31)P NMR and enzyme activity study.

  2000cited by this paper
• Natural and synthetic endocannabinoids and their structure-activity relationships.

  2000cited by this paper
• Phospholipase D: molecular and cell biology of a novel gene family.

  2000cited by this paper
• Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide*

  2000cited by this paper
• The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes.

  2000cited by this paper
• Endocannabinoids: new targets for drug development.

  2000cited by this paper
• Determination of the Phospholipid Precursor of Anandamide and Other N‐Acylethanolamine Phospholipids Before and After Sodium Azide‐Induced Toxicity in Cultured Neocortical Neurons

  2000cited by this paper
• Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.

  1999cited by this paper
• Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

  1999cited by this paper
• GC/MS Analysis of Anandamide and Quantification of N‐Arachidonoylphosphatidylethanolamides in Various Brain Regions, Spinal Cord, Testis, and Spleen of the Rat

  1999cited by this paper
• Chronic Ethanol Increases the Cannabinoid Receptor Agonist Anandamide and Its Precursor N‐Arachidonoylphosphatidylethanolamine in SK ‐ N ‐ SH Cells

  1999cited by this paper
• Structural determinants for recognition and translocation by the anandamide transporter.

  1999cited by this paper
• Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme.

  1999cited by this paper
• Anandamide activates human platelets through a pathway independent of the arachidonate cascade

  1999cited by this paper
• Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis(1).

  1999cited by this paper
• Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

  1999cited by this paper
• Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with Ionomycin

  1999cited by this paper
• Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.

  1999cited by this paper
• Interactions between synthetic vanilloids and the endogenous cannabinoid system

  1998cited by this paper
• Endocannabinoids.

  1998cited by this paper
• The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.

  1998cited by this paper
• An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

  1998cited by this paper
• Anandamide Hydrolysis by Human Cells in Culture and Brain*

  1998cited by this paper
• A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.

  1998cited by this paper
• 2‐Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2+‐dependent and ‐independent mechanisms

  1998cited by this paper
• Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation.

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand

  1998cited by this paper
• Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator?

  1998cited by this paper
• 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

  1998cited by this paper
• Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

  1997cited by this paper
• Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

  1997cited by this paper
• The biodisposition and metabolism of anandamide in mice.

  1997cited by this paper
• A second endogenous cannabinoid that modulates long-term potentiation

  1997cited by this paper
• cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase

  1997cited by this paper
• Biosynthesis of 2-arachidonoyl-glycerol, a novel cannabimimetic eicosanoid, in mouse neuroblastoma cells.

  1997cited by this paper

• The cannabinoid receptor 2 is an in vivo receptor of bisphenol A during bone formation.

  2026cites this paper
• Cannabinoid pharmacology: Research on medicinal cannabins and its therapeutic application

  2025cites this paper
• Radiosynthesis and evaluation of novel 18F labeled PET ligands for imaging monoacylglycerol lipase.

  2025cites this paper
• Characterizing the Role of Endocannabinoid Receptor Cnr1 in Mouse Ovarian Granulosa Cells

  2025cites this paper
• Sub-lethal imidacloprid exposure leads to presynaptic and postsynaptic alterations

  2025cites this paper
• From Synaptic Plasticity to Neurotoxicity: Endocannabinoid Influence on Addiction and Neurodegeneration

  2025cites this paper
• Nerol enhances lipid synthesis in human sebocytes via cannabinoid receptor-2-mediated MAPK signaling.

  2025cites this paper
• Role of the Endocannabinoid System in Fibromyalgia

  2025cites this paper
• Therapeutic Potential of Cannabis Plant in Diabetes

  2025cites this paper
• “Elucidating the immunomodulatory role of endocannabinoids in intervertebral disc degeneration”

  2024cites this paper
• Dynamic Mechanism for Subtype Selectivity of Endocannabinoids

  2024cites this paper
• Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders.

  2024cites this paper
• In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution

  2024cites this paper
• Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence

  2024cites this paper
• The role of the key endocannabinoids and their receptros in breast cancer

  2024cites this paper
• A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders

  2024cites this paper
• Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus)

  2024cites this paper
• Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans

  2024cites this paper
• A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory

  2024cites this paper
• Endocannabinoids and atherosclerosis: the future of therapeutic strategies—a review

  2024cites this paper
• Interoceptive regulation of skeletal tissue homeostasis and repair

  2023cites this paper
• Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments.

  2023cites this paper
• Cannabinoid regulation of neurons in the dentate gyrus during epileptogenesis: Role of CB1R‐associated proteins and downstream pathways

  2023cites this paper
• Integrative approach to the therapeutic use of cannabis for orofacial pain

  2023cites this paper
• ENDOCANNABINOID SYSTEM IN THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS MODULATES AUTONOMIC AND CARDIOVASCULAR CHANGES BUT NOT VASOPRESSIN RESPONSE IN A RAT HEMORRHAGIC SHOCK MODEL

  2023cites this paper
• UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

  2023cites this paper
• The effect of N-arachidonoylethanolamide administration on energy and fat metabolism of early lactating dairy cows

  2023cites this paper
• Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

  2022cites this paper
• Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.

  2022cites this paper
• Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery

  2022cites this paper
• Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone

  2022influential citation
• Overview of the Endocannabinoid System and Endocannabinoidome

  2022cites this paper
• Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective

  2022cites this paper
• 2-AG and anandamide enhance hippocampal long-term potentiation via suppression of inhibition

  2022influential citation
• nZVI-induced iron poisoning aggravated the toxicity of TCEP to earthworm in soil.

  2022cites this paper
• Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain

  2022cites this paper
• Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

  2022cites this paper
• Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model.

  2022cites this paper
• The Effect of Marijuana on the Incidence and Evolution of Male Infertility: A Systematic Review

  2021cites this paper
• Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health

  2021cites this paper
• Cannabinoid Receptor II engagement promotes ILC2 expansion and enhances ILC2-dependent airway hyperreactivity.

  2021cites this paper
• Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasis

  2021cites this paper
• Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases

  2021cites this paper
• Cannabinoids differentially modulate behavioral and developmental responses to ethanol in Drosophila

  2021cites this paper
• Cannabinoids and sleep-wake cycle: The potential role of serotonin.

  2021cites this paper
• The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?

  2021cites this paper
• The Endocannabinoidome in Neuropsychiatry: Opportunities and Potential Risks.

  2021cites this paper
• Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

  2021cites this paper
• A common genetic variant in fatty acid amide hydrolase is linked to alterations in fear extinction neural circuitry in a racially diverse, nonclinical sample of adults

  2021cites this paper
• Cannabinoid Signaling in Auditory Function and Development

  2021cites this paper
• Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review

  2021influential citation
• At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk

  2021cites this paper
• Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders

  2021influential citation
• Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.

  2021cites this paper
• A proposed modulatory role of the endocannabinoid system on adipose tissue metabolism and appetite in periparturient dairy cows

  2021influential citation
• The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?

  2021cites this paper
• Obesity Impairs Short-Term and Working Memory through Gut Microbial Metabolism of Aromatic Amino Acids.

  2020cites this paper
• Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation

  2020cites this paper
• The Cannabinoids Effect on Bone Formation and Bone Healing

  2020cites this paper
• Cannabinoids and inflammation: Implications for People Living with HIV.

  2019cites this paper
• Endocannabinoid System and Alcohol Abuse Disorders.

  2019cites this paper
• Modulation of the Endocannabinoid System Following Central Nervous System Injury

  2019cites this paper
• Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications.

  2019cites this paper
• Recent Advances in Cannabinoid Physiology and Pathology

  2019cites this paper
• 2-Arachidonoylglycerol enrichment Reduced Epileptiform Activity of the Rat Hippocampus induced with Pentylenetetrazol

  2018cites this paper
• Imaging alterations in endocannabinoid metabolism in clinical high risk for psychosis: The first cohort of a PET study using [11C]CURB

  2018cites this paper
• The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.

  2018influential citation
• The endocannabinoid system during the postnatal development of the rat cerebellum )

  2018cites this paper
• Orexin A presynaptically decreases inhibitory synaptic transmission in rat locus coeruleus neurons.

  2018cites this paper
• Glial endocannabinoid system in pain modulation

  2018influential citation
• Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders

  2018cites this paper
• The cannabinoid transporter inhibitor OMDM‐2 reduces social interaction: Further evidence for transporter‐mediated endocannabinoid release

  2018cites this paper
• Factors influencing the specificity and bias of CB1 cannabinoid receptor signalling

  2018cites this paper
• Heterómeros de receptores CB1, CB2 y GPR55 y su implicación en enfermedades neurodegenerativas y alcoholismo

  2018cites this paper
• Cannabinoid signaling in health and disease.

  2017cites this paper
• Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans

  2017cites this paper
• Role of Cannabinoid Receptor Type 2 (CB2) in Late Stage Atherosclerosis

  2017cites this paper
• N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation-induced apoptosis through inhibiting anandamide inactivation system.

  2017cites this paper
• Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.

  2017cites this paper
• Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor

  2017cites this paper
• Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine

  2017cites this paper
• Protein purification and cloning of diacylglycerol lipase from rat brain.

  2016cites this paper
• Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

  2016influential citation
• Investigating the effect of enzymatic elimination of endocannabinoids inhibitors on tonic- colonic seizure provoked by PTZ

  2016influential citation
• From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.

  2016cites this paper
• The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone‐Induced Central Nervous System Demyelination

  2016cites this paper
• Syntheses and Evaluation of Novel Cannabinoid Type 2 Receptors Tracers for PET Imaging

  2015cites this paper
• CANNABINOID INDUCED CHANGES IN RAT UTERINE CONTRACTILITY

  2015cites this paper
• Modulation of Cannabinoid Receptor Activity by Allosteric Modulators, Inverse Agonists and Receptor Binding Partners

  2015cites this paper
• Endocannabinoid transport revisited.

  2015cites this paper
• Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling

  2015cites this paper
• Syntheses and Evaluation of Novel Cannabinoid Type 2 Receptors Tracers for PET Imaging

  2015cites this paper
• Cannabinoid system combined to classic targets for a new MTDL strategy: design and synthesis of natural inspired molecules for Alzheimer's disease

  2015cites this paper
• Increased Angiotensin II Contraction of the Uterine Artery at Early Gestation in a Transgenic Model of Hypertensive Pregnancy Is Reduced by Inhibition of Endocannabinoid Hydrolysis

  2014cites this paper
• Arquitectura subcelular del sistema endocannabinoide en el núcleo ventromedial del hipotálamo de ratón

  2014influential citation
• Identification and characterization of a major prostaglandin glycerol ester hydrolase in human cancer cells

  2014cites this paper
• Subcellular localization of NAPE-PLD and DAGL-α in the ventromedial nucleus of the hypothalamus by a preembedding immunogold method

  2014cites this paper
• Rôle et implication du système cannabinoïde dans la modulation périphérique de la douleur inflammatoire et neuropathique

  2014cites this paper
• The biological networks in studying cell signal transduction complexity: The examples of sperm capacitation and of endocannabinoid system

  2014cites this paper
• Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats.

  2014cites this paper